Download - Morris on Crit Care Haem Malignancies
![Page 1: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/1.jpg)
Critical Care 2012 - Haematology
Daydream Island, 27-09-12
Ed Morris, Consultant HaematologistTownsville Cancer Centre
![Page 2: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/2.jpg)
Case: Mr CS
April 2004:
• 50 yrs, previously fit and well prison guard
• Presented to GP with back pain and lethargy
![Page 3: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/3.jpg)
Case: Mr CS
![Page 4: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/4.jpg)
Case: Mr CS
![Page 5: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/5.jpg)
Case: Mr CS
![Page 6: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/6.jpg)
Case: Mr CS
![Page 7: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/7.jpg)
Bone Marrow Biopsy
![Page 8: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/8.jpg)
Multiple myeloma
• Clonal plasma cell malignancy
• CRAB
• Hyper-Calcaemia
• Renal failure
• Anaemia
• Bone disease
• Incurable
![Page 9: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/9.jpg)
Multiple myeloma
![Page 10: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/10.jpg)
Multiple myeloma
![Page 11: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/11.jpg)
• HDT: High Dose Therapy
• ASCT: Autologous Stem Cell Transplant
![Page 12: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/12.jpg)
Case: Mr CS
• VAD induction chemotherapy
• Vincristine, Adriamycin and Dexamethasone
• 96 hour continuous infusion via Portacath
• Good response
• Autologous peripheral blood stem cell transplant
• High dose Melphalan conditioning (200mg/m2)
![Page 13: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/13.jpg)
Prognosis
• International Staging System (ISS)
Stage Albumin
B2M
1 >35 <3.52 <35 3.5-
5.53 <35 >5.5
![Page 14: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/14.jpg)
Prognosis
• International Staging System (ISS)
Stage Albumin
B2M
1 >35 <3.52 <35 3.5-
5.53 <35 >5.5
![Page 15: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/15.jpg)
Prognosis
Greipp P R et al. JCO 2005;23:3412-3420
![Page 16: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/16.jpg)
2005-2006
2006 - Floyd Landis
2005
2006 – Oscar Pereiro
![Page 17: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/17.jpg)
Case: Mr CS
September 2006 (~2 years post-transplant)
• Increasing serum paraprotein
• Falling Hb
• BM Bx: 43% plasma cells
• Progressive disease
![Page 18: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/18.jpg)
Relapsed incurable malignancy
Re-treat or palliative care?
• Already survived predicted median OS
• ? further Rx options
![Page 19: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/19.jpg)
Relapsed incurable malignancy
Re-treat or palliative care?
• Already survived predicted median OS
• ? further Rx options
BUT
• 52 yrs old
• Normal performance status and good QOL
![Page 20: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/20.jpg)
![Page 21: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/21.jpg)
Case: Mr CS
• Oral CTD x4
• Cyclophosphamide, Thalidomide and Dexamethasone
• Good response
• 2nd autologous peripheral blood stem cell transplant
• High dose Melphalan conditioning (200mg/m2)
![Page 22: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/22.jpg)
Case: Mr CS
• D+8 post-transplant
• Unwell
• Temp 39oc
• Multiple cultures negative
• Started Tazocin + Vancomycin
![Page 23: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/23.jpg)
Case: Mr CS
• D+10 post-transplant
• Very unwell
• Temp 39oc
• P135 regular, BP 80/55
• Respiratory compromise
• RR 24, O2 Sat 88% on 10L
• Ambisome added + ICU consult
![Page 24: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/24.jpg)
Case: Mr CS
• Would ICU admission be appropriate?
![Page 25: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/25.jpg)
Case: Mr CS
• Would ICU admission be appropriate?
Yes No
Normal functional status pre-transplant
Relapsed incurable malignancy
Good response to salvage chemo
Has used all currently available Rx
Transient BM “failure” Predicted PFS < before
Renal, etc OK APACHE III score 122
![Page 26: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/26.jpg)
TTH ICU Data 2003-2011
Anni Paasilahti 2012 (Senior Registrar ICU, TTH)
![Page 27: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/27.jpg)
APACHE III score 122
Anni Paasilahti 2012 (Senior Registrar ICU, TTH)
![Page 28: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/28.jpg)
Case: Mr CS
• Admitted ICU
• CPAP, IV antibiotics, Vasopressor support
• Excellent response
• Discharged ICU after 48hrs
![Page 29: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/29.jpg)
Case: Mr CS
• Rapid improvement back on ward
• Blood counts recovered
• Discharged hospital D+26 post-transplant
• Commenced Thalidomide maintenance D+70
![Page 30: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/30.jpg)
2007-2009
2007 – Alberto Contador
2008 – Carlos Sastre 2009 – Alberto Contador
![Page 31: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/31.jpg)
Case: Mr CS
March 2009 (5 yrs post-diagnosis)
• Increasing serum paraprotein
• Falling Hb
• BM Bx: 31% plasma cells
• Progressive disease
![Page 32: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/32.jpg)
Relapsed incurable malignancy
Re-treat or palliative care?
• Already survived >>> predicted median OS
• ? further Rx options
BUT
• 55 yrs old
• Normal performance status and good QOL
• 2+ yrs since we last considered palliation
![Page 33: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/33.jpg)
NEJM 2008; 359; 906-17
![Page 34: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/34.jpg)
NEJM 2008; 359; 906-17
![Page 35: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/35.jpg)
Case: Mr CS
• CyBorD
• Cyclophosphamide, Bortezomib (Velcade), Dexamethasone
• SE: peripheral neuropathy
• Velcade maintenance
![Page 36: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/36.jpg)
Case: Mr CS
• August 2012
• 8 yrs post-diagnosis
• Well
• Good QOL
• Myeloma in remission
![Page 37: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/37.jpg)
Case: Mr CS
• Is he cured?
• No, but he may still live a number of years
• Does he have further treatment options?
• Lenalidomide
• Lenalidomide + Velcade combinations
• Pomalidomide
• Carfilzomib, etc etc
![Page 38: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/38.jpg)
Myeloma 1998: Life expectancy 2-3 years
Infu
sion
al V
AD
Auto
logou
s Ste
m c
ell
transp
lan
t
Salv
age a
ttem
pts
DEATH
![Page 39: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/39.jpg)
Myeloma 2012: Life expectancy 10+ years
Th
alid
om
ide-b
ase
d R
x
Auto
logou
s Ste
m c
ell
transp
lan
t
Main
tenan
ce T
halid
om
ide
Valc
ade-b
ase
d R
x
2n
d A
uto
logous
Ste
m c
ell
transp
lant
Main
tenan
ce V
elc
ade
Lenalid
om
ide-b
ase
d R
x
Main
tenan
ce L
en
alid
om
ide
![Page 40: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/40.jpg)
Monoclonal antibodies
![Page 41: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/41.jpg)
Monoclonal antibodies – flow cytometry
CD20
Anti-CD20
Fluorochrome
CD5
Anti-CD5
Different fluorochrome
![Page 42: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/42.jpg)
Monoclonal antibodies – flow cytometry
CD5
CD
20
100 101 102 103 104
CD3 FITC
Gp 1 CD3 Neg PE NK1.1 .001
100 101 102 103 104
CD3 FITC
Gp 1 CD3 Neg PE NK1.1 .001
R2
R3
R4
![Page 43: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/43.jpg)
Monoclonal antibodies – therapeutic agents
• Rituximab (Mabthera)
![Page 44: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/44.jpg)
Mrs TS
• 59 yr old female
• Diagnosed Follicular Lymphoma March 2008
• R-CHOP x6
• Good response
![Page 45: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/45.jpg)
Haematologica 2007; 92; 826-831
![Page 46: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/46.jpg)
Mrs TS
• 59 yr old female
• Diagnosed Follicular Lymphoma March 2008
• R-CHOP x6
• Good response
• Mabthera every 2 months (planned for 2 years)
![Page 47: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/47.jpg)
Mrs TS
• Relapsed FL August 2011
• Salvage R-ICE – good response
• Standard practice: consolidation with high dose chemo (BEAM) + autologous stem cell transplant
![Page 48: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/48.jpg)
Cancer 2012; in press
![Page 49: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/49.jpg)
Mrs TS
• Consolidation Z-BEAM + autologous stem cell transplant
![Page 50: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/50.jpg)
Mr JS
• 68 yr old male
• Diagnosed Hodgkin’s Lymphoma July 2009
• ABVD x6
• Good response
• Relapsed August 2010
• ESHAP salvage
• BEAM + autologous stem cell transplant
![Page 51: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/51.jpg)
Mr JS
• 2nd relapsed July 2012
• ICE salvage
• Poorly tolerated
• Disease progression during chemo
• Options?
• Palliative care
• Experimental Rx
![Page 52: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/52.jpg)
CD30+ Reed-Sternberg Cell
Reed-sternberg cell CD15+, CD30+, CD20-
Brentuximab vedotin
![Page 53: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/53.jpg)
![Page 54: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/54.jpg)
End-stage Hodgkin’s (relapse post transplant)
![Page 55: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/55.jpg)
Mrs AB
• 43 yr old female
• Diagnosed Ph+ ALL April 2009
• Rx: BFM-based intensive chemo followed by allogeneic stem cell transplant
• Relapsed January 2011
• Prognosis extremely poor
• Options???
![Page 56: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/56.jpg)
BiTE Antibodies
![Page 57: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/57.jpg)
Mrs AB
• Travelled to Germany: Phase 2 study of Blinatumomab
• 6 months later:
• In complete remission…
![Page 58: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/58.jpg)
Myeloma 1998: Life expectancy 2-3 years
Infu
sion
al V
AD
Auto
logou
s Ste
m c
ell
transp
lan
t
Salv
age a
ttem
pts
DEATH
![Page 59: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/59.jpg)
Myeloma 2012: Life expectancy 10+ years
Th
alid
om
ide-b
ase
d R
x
Auto
logou
s Ste
m c
ell
transp
lan
t
Main
tenan
ce T
halid
om
ide
Valc
ade-b
ase
d R
x
2n
d A
uto
logous
Ste
m c
ell
transp
lant
Main
tenan
ce V
elc
ade
Lenalid
om
ide-b
ase
d R
x
Main
tenan
ce L
en
alid
om
ide
![Page 60: Morris on Crit Care Haem Malignancies](https://reader033.vdocument.in/reader033/viewer/2022061111/54559ed9af79595d048b5528/html5/thumbnails/60.jpg)
Questions?
Isabella Morris Age 4yrs